Inmunomodulación Tumoral |

Publicaciones

2025

Redin, E, Otegui, N, Santos, M, Leon, S, Redrado, M, Serrano, D, de Pierola, EF, Russo-Cabrera, JS, Ferrer, I, Olmedo, M, Diaz-Lagares, A, Houry, M, Vicent, S, Vilalta, A, Mondelo-Macía, P, García-González, J, León-Mateos, L, Gonzalez, A, Paz-Ares, L, López, R, Sanmamed, MF, Montuenga, L, Calvo, A (2025).

Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy

CANCER RESEARCH. Article. 85(20):3910-3929.
[doi:10.1158/0008-5472.CAN-24-2772]

Cirauqui, C, Ojeda, L, Otano, I, Pazos, I, Santos, A, Garrido-Martín, EM, Yagüe, P, Ramos-Paradas, J, Molina-Pinelo, S, Roncador, G, Solórzano, JL, Muñoz, MT, Cozar, P, Plaza, P, Suárez, R, Jiménez, M, Moreno, R, Rosado, A, Gámez, P, García-Luján, R, Zugazagoitia, J, Sweet-Cordero, EA, Barbacid, M, Carnero, A, Ferrer, I, Paz-Ares, L (2025).

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion

Clinical and Translational Medicine. Article. 15(7).
[doi:10.1002/ctm2.70374]

2023

Singh, KP, Pallett, LJ, Singh, H, Chen, A, Otano, I, Duriez, M, Rombouts, K, Pinzani, M, Crane, M, Fusai, G, Avihingsanon, A, Lewin, SR, Maini, MK (2023).

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection

AIDS. Article. 37(3):401-411.
[doi:10.1097/QAD.0000000000003435]

Otano, I, Ucero, AC, Zugazagoitia, J, Paz-Ares, L (2023).

At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC

Nature Reviews Clinical Oncology. Review. 20(3):143-159.
[doi:10.1038/s41571-022-00718-x]

Inmunomodulación Tumoral

Publicaciones

2025

Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion

2023

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection

At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC

Uso de cookies